Other immune-related signatures, such as IFN gamma (28), immune checkpoint (29), and hot tumor (30) were higher in AA1 (Figures 4F-H), which indicated that AA1 may benefit more from immunotherapy. The gene discussed is IFNG; the disease is neoplasm.